Background: Procalcitonin (PCT) is a biomarker that has been proposed as a helpful tool in inflammatory Clinique cases specially patient with pulmonary bacterienne infection . Materials and methods the investigatore had retrospectively reviewed the electronic records and lists of all 582 COVID-19 patients admitted on the ICU of Hospital university Mohammed VI , Oujda. Between 01 juin 2020 and 31juanary 2021 , and analyzed the relation of PCT value and mortality at 30 days until we can defined a cut off Procalcitonine to use as a marker of severity and high mortality .
Our objective is to assess the relationship between Procalcitonin and 30-day mortality in patients admitted to the resuscitation department of the Mohammed VI University Hospital Center, Oujda, Morocco, infected by the SARS COV 2 Virus .
Study Type
OBSERVATIONAL
Enrollment
582
younes Oujidi
Berkane, Morocco
Procalcitonin is a marker of mortality
as a cutoff 0.5 ng/ml Procalcitonin could be used as mortality factors
Time frame: through study completion, an average of 8 mounths
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.